Official Title
Intraarticular Injections of the Hip and Knee With Triamcinolone Versus Ketorolac: A Randomized Controlled Trial
Phase
Phase 2/Phase 3Lead Sponsor
Saint Alphonsus Regional Medical CenterStudy Type
InterventionalStatus
Completed No Results PostedIndication/Condition
Arthritis Knee Arthritis of HipIntervention/Treatment
Ketorolac Intraarticular Injection Triamcinolone Intraarticular InjectionStudy Participants
120Clinicians commonly utilize intraarticular injections to treat symptomatic primary arthritis. Steroid injections are common yet have immune-modulating effects and can alter gene expression which may delay definitive arthroplasty and further damage cartilage. Non-steroidal anti-inflammatory (NSAID) injections may offer a safer profile due to their differing mechanism of action; however, there is a relative dearth of information regarding their efficacy. This non-inferiority study compares the effectiveness of triamcinolone versus ketorolac in treating symptoms of moderate to advanced primary osteoarthritis of the hip and knee.
Injections will be given under ultrasound guidance with one of two possible medications.
Injections will be given under ultrasound guidance with one of two possible medications.
Patients will receive an intraarticular hip injection with ketorolac.
Patients will receive an intraarticular hip injection with triamcinolone.
Patients will receive an intraarticular knee injection with ketorolac.
Patients will receive an intraarticular knee injection with triamcinolone.
Inclusion Criteria: Symptomatic, radiographically proven degenerative joint disease in the hip or knee Exclusion Criteria: recent injection in the hip or knee within the previous 3 months history of traumatic osteoarthritis or ligamentous reconstruction chronic narcotic use history of inflammatory or neuropathic arthropathy pregnant and/or nursing women allergy or strong reaction to study medications